PregnanTech

PregnanTech Overview

PregnanTech is developing the Lioness, a small, disposable device designed to maintain the natural resistance of the cervix in order to prevent preterm birth. The Lioness is positioned around the uterine cervix and behaves like a shock absorber, allowing transient shortening and dilation of the cervix during contractions and then restoring the cervix to its initial state when contractions subside. The device is inserted by a physician during an outpatient visit and removed at term. PregnanTech has conducted a range of successful preclinical studies and in 2019 began a clinical safety study of Lioness among non-pregnant women intended for hysterectomy. Initial findings demonstrate the significant potential inherent in the device. Professor Kypros Nicolaides, a preeminent obstetrician from Kings College Hospital in London, has expressed his interest in leading a first clinical trial in 2021 among pregnant women at risk of preterm birth. PregnanTech is part of the Trendlines Group.

Cumulative Funding Raised Over Time ($)

Latest News

Jul 21, 2024 · www.prnewswire.com

growth-positive

Confronting the Preterm Birth Crisis: A New Hope on the Horizon

PregnanTech, a medical technology company, has introduced LIONESS™, a non-surgical device designed to reduce preterm birth (PTB) rates. The device, a silicone ring placed around the cervix, has shown promising results in clinical trials, with a high rate of term births and no significant side effects. The company plans to conduct a pivotal study in the United States in 2025 to further prove the devices efficacy and support the FDA approval process. LIONESS™ offers a new hope for families at risk of PTB, potentially saving tens of thousands of babies annually.

Product StageFDA approved/pending approval

Sep 22, 2020 · biotuesdays.com

growth-positive

Trendlines' PregnanTech developing Lioness device to prevent preterm birth - BioTuesdays

PregnanTech, a medical technology company, is conducting a clinical safety study with its Lioness device to prevent preterm birth. The CEO, Dr. David Shashar, believes that Lioness has the potential to reduce the rate of preterm birth and improve outcomes for neonates. The device is a disposable silicone ring placed in the vagina and secured around the uterine cervix to keep it elongated and closed. PregnanTech plans to conduct a larger proof-of-concept study in 2021 and is raising $1.1 million for its trials. The company also has plans for a pivotal study in 2022-2023 to seek regulatory approval and begin sales in the U.S. and Europe in 2024. PregnanTechs target market includes obstetric and gynecology clinics and obstetric hospital departments.

InvestmentExpand

Aug 6, 2020 · www.medgadget.com

growth-positive

LIONESS Device to Help Prevent Preterm Birth

PregnanTech, an Israeli company, has developed an implantable device called LIONESS that aims to prevent premature birth. The device reduces the load on the cervix, delays the biomechanical cascade, and prevents spontaneous birth. It is currently being tested in a clinical safety trial and is planned to be trialed at Kings College Hospital in London next year. The CEO of PregnanTech highlights the importance of each additional week in the womb for fetal development and the lack of successful solutions for preventing premature birth. The company sees a large target market and potential breakthrough in the medical field.

Customers

Aug 3, 2020 · www.jpost.com

growth-positive

https://www.jpost.com/health-science/novel-device-that-prevents-preterm-birth-developed-in-israel-637220

Israeli company PregnanTech has developed a medical device called Lioness to prevent premature birth. The device, a silicon ring placed around the uterine cervix, aims to delay preterm birth by keeping the cervix elongated and closed. PregnanTech is conducting a clinical trial to evaluate the safety of Lioness and plans to conduct a second trial with pregnant women at risk for preterm birth. The company estimates the market potential for Lioness to be over $2 billion annually in developed countries alone. PregnanTech is open to investment to support the product.

CustomersInvestment

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Misgav Industrial Park, Tchelet Street 17, Israel

Photos & Videos

1 item(s)

PregnanTech Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info